1 Cash-Rich Dividend Legend Retirees Can Lean On Even If Rate Hikes Return

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Nike's 30% YTD collapse has pushed NKE's yield to 3.58%, while $3.27 billion in free cash flow comfortably covers the $2.30 billion dividend payout.

  • CEO Elliott Hill purchased 47,320 Nike shares near $42, with director Tim Cook buying shortly after, signaling board-level conviction in the dividend streak.

  • This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants like General Motors, but only through July 16. (sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
1 Cash-Rich Dividend Legend Retirees Can Lean On Even If Rate Hikes Return

© Jack_the_sparow / Shutterstock.com

Wall Street is treating Nike (NYSE:NKE | NKE Price Prediction) like a broken brand, but the dividend tells a different story. After a 29.55% YTD slide to $44.19, the yield has climbed to 3.58%, the richest level in years. With the Fed signaling higher-for-longer rates, I want to know whether this payout is built to last.

Dividend Snapshot

Metric Value
Annual Dividend $1.64 run-rate
Dividend Yield 3.58%
Consecutive Years of Increases 24 years
Most Recent Increase 2.5% (November 2025)
Aristocrat Status Not yet (one year away)

Free Cash Flow Still Covers the Check

The earnings ratio looks ugly. Trailing EPS of $1.51 against a $1.62 TTM dividend gives an earnings payout above 100%. Cash flow is the better lens. In FY2025, Nike generated $3.27 billion in free cash flow against $2.30 billion in dividends paid.

Metric TTM Value Assessment
Earnings Payout Ratio Above 100% Elevated
FCF Payout Ratio 70% Elevated but covered
Operating Cash Flow Coverage 1.61x Adequate

A Balance Sheet That Laughs at Rate Hikes

This is where the “cash-rich” label earns its keep. Nike sits on $6.66 billion in cash against $14.09 billion of equity. Even with $22.97 billion in total liabilities, EBITDA of $3.86 billion easily services debt. A hawkish Fed barely registers here.

24 Years of Increases, and Counting

Fiscal Year Annual Dividend
2025 $1.61
2024 $1.51
2023 $1.39
2022 $1.255
2021 $1.13

Growth is decelerating. The last raise was just 2.5%, well below the 8%-plus bumps in 2023 and 2024. The streak is intact, but management is clearly conserving cash during the turnaround.

Management Puts Money Behind the Words

CEO Elliott Hill told investors, “NIKE is in the middle innings of our comeback”, and he backed it with personal capital. In April, Hill purchased 47,320 shares near $42.27, joined within days by directors Tim Cook and Robert Swan. CFO Matthew Friend cautioned the recovery “will not be linear”, but neither executive hedged on the payout.

The Verdict: Safe, but Growth Is Resting

Dividend Safety Rating: Safe. The FCF payout at 70% is elevated yet covered, the cash pile is fortress-grade, and 24 years of increases plus open-market CEO buying tell me this board will defend the streak. Nike screens as an income holding if the “Win Now” plan stabilizes margins in FY2027. The risk case is tariffs and Greater China weakness forcing another year of -34% net income declines. Net-net, the dividend itself looks insulated from Fed noise. The next raise will be small, but it is coming.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561